Skip to main content
Matthew Hemming, MD, Oncology, Worcester, MA

Matthew Louis Hemming MD PhD

Hematologic Oncology, Sarcoma


Sarcoma and Bone Oncology

Join to view full profile
  • 55 Lake Ave NWorcester, MA 01655

  • Phone+1 508-334-3550

  • Fax+1 774-442-9130

Dr. Hemming is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2014 - 2017
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2015
  • Harvard Medical School
    Harvard Medical SchoolClass of 2012
  • Harvard University
    Harvard UniversityPhD, 2007

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2015 - 2027
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Translational Insights into Gastrointestinal Stromal Tumor and Current Clinical Advances  
    M C Heinrich, S George, M L Hemming, Annals of Oncology

Lectures

  • Identification of leiomyosarcoma circulating tumor DNA through ultra-low passage whole genome sequencing and correlation with tumor burden: A pilot experience. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Grant Support

  • Defining clinically relevant transcriptional networks in gastrointestinal stromal tumorUNIV OF MASSACHUSETTS MED SCH WORCESTER2020–2025
  • Defining clinically relevant transcriptional networks in gastrointestinal stromal tumorUNIV OF MASSACHUSETTS MED SCH WORCESTER2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: